Research location
Lido di Camaiore
Italy
Advertisement
Research activity in Lido di Camaiore
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 34 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lido di Camaiore
34 linked trials · page 1 of 1Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and SurveillanceNCT07855679 · 2026-06-19 · 1 site observation
RECRUITING
Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).NCT06663098 · 2025-01-24 · 1 site observation
RECRUITING
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on LorlatinibNCT06378892 · 2024-03-15 · 1 site observation
RECRUITING
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System PacingNCT06324682 · 2023-01-01 · 1 site observation
RECRUITING
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesNCT05081609 · 2022-01-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in ItalyNCT04463108 · 2020-06-23 · 1 site observation
COMPLETED
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer PatientsNCT05730647 · 2019-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)NCT02395172 · 2015-03-24 · 1 site observation
COMPLETED
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsNCT02175446 · 2014-09-01 · 1 site observation
UNKNOWN
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and CarboplatinNCT01285609 · 2011-01-16 · 1 site observation
COMPLETED
Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer PatientsNCT01202591 · 2010-12-01 · 1 site observation
COMPLETED
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's DiseaseNCT01127633 · 2010-12-01 · 1 site observation
TERMINATED
Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung CancerNCT01211483 · 2010-09-01 · 1 site observation
COMPLETED
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung CancerNCT01107444 · 2010-05-01 · 1 site observation
COMPLETED
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOnNCT01055379 · 2010-03-01 · 1 site observation
COMPLETED
Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's DiseaseNCT00986414 · 2009-09-01 · 1 site observation
COMPLETED
Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)NCT00900627 · 2009-06-01 · 1 site observation
COMPLETED
Effect of LY2062430 on the Progression of Alzheimer's DiseaseNCT00904683 · 2009-05-01 · 1 site observation
COMPLETED
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINNCT00831909 · 2009-01-01 · 1 site observation
COMPLETED
A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung CancerNCT00789373 · 2008-11-01 · 1 site observation
COMPLETED
The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4NCT00497146 · 2008-02-01 · 1 site observation
COMPLETED
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseNCT00335153 · 2008-01-01 · 1 site observation
COMPLETED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
MOTION, Safinamide in Early IPD, as add-on to Dopamine AgonistNCT00605683 · 2007-11-01 · 1 site observation
COMPLETED
An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsNCT00335374 · 2007-08-01 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's DiseaseNCT00437125 · 2007-03-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
Transdermal Rotigotine User Surveillance StudyNCT00599339 · 2006-06-01 · 1 site observation
COMPLETED
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor FluctuationsNCT00286897 · 2006-02-01 · 1 site observation
COMPLETED
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa TherapyNCT00099268 · 2004-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseNCT00099242 · 2003-11-01 · 1 site observation
COMPLETED
A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and EfficacyNCT00407212 · 2002-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.